Application of Chimeric Antigen Receptor T Cells in the Treatment of Hematological Malignancies
Weiqi Yan(Beijing Advanced Sciences and Innovation Center), Jian Yu(Queen's University), Zhuojun Liu(Peking University), Yuanshi Xia(Beihang University), Jia Liu(Frederick National Laboratory for Cancer Research), Kai Hu(Beijing Tongren Hospital)
Cited by 16
Related Papers
Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation
|Journal of Clinical Investigation|2015|186
High-level ROR1 associates with accelerated disease progression in chronic lymphocytic leukemia
|Blood|2016|144
Bi-paratopic and multivalent VH domains block ACE2 binding and neutralize SARS-CoV-2
|Nature Chemical Biology|2020|114
Linearized polynomials over finite fields revisited
|Finite Fields and Their Applications|2013|102
Extinction and permanence in nonautonomous competitive system with stage structure
|Journal of Mathematical Analysis and Applications|2002|76